Circadian rhythms of thyroid hormones in patients with ischemic heart disease, arterial hypertension, and atrial fibrillation
https://doi.org/10.18087/cardio.2506
Abstract
Aim. To evaluate the interrelationship between diurnal changes in thyrotropic hormone (TTH), free triiodothyronine (FT3), and clinical features of IHD in combination with AH and atrial fibrillation (AF). Materials and methods. Levels of TTH, FT3, and plasma cortisol were measured in 133 patients with IHD and AH with or without paroxysmal AF. The studied indexes included duration of IHD, AH, and AF; presence or absence of AF and AH; incidence rate of AF episodes per week; severity of exertional angina; systolic and diastolic BP; and EchoCG data. Results. Morning and evening TTH levels were significantly different and reached high values in the morning and low values in the evening in most patients (n=91; 68.4%). A part of patients (n=42; 31.6%) showed an opposite tendency with high TTH values in the evening, i.e., inversion of the TTH fluctuations. Such patients more often had a history of myocardial infarction, a high class of exertional angina, and recurrence of paroxysmal AF. Patients with the TTH inversion had a shorter AH duration but somewhat higher BP. Conclusion. A part of IHD patients had inversed TTH circadian changes associated with more severe clinical manifestations of cardiovascular pathology.
About the Authors
Yu. O. Tsareva
V.I. Razumovsky Saratov State Medical University, Bolshaya Kazachjya 112, Saratov 410012
Russian Federation
Russian Federation
E. A. Mayskova
V.I. Razumovsky Saratov State Medical University, Bolshaya Kazachjya 112, Saratov 410012
Russian Federation
Russian Federation
E. A. Fedotov
LLC Medical Di-Center, Moskovskaya Str. 23, Saratov 410000
Russian Federation
Russian Federation
Yu. G. Shvarts
V.I. Razumovsky Saratov State Medical University, Bolshaya Kazachjya 112, Saratov 410012
Russian Federation
Russian Federation
References
1. Kaminski G, Makowski K, Michałkiewicz D, Kowal J, Ruchala M, Szczepanek E et al. The Influence of Subclinical Hyperthyroidism on Blood Pressure, Heart Rate Variability, and Prevalence of Arrhythmias. Thyroid. 2012;22(5):454–60. DOI: 10.1089/thy.2010.0333
2. Zakharenko R. V. Clinical aspects of thyroid diseases in patients with cardiac pathology. Far Eastern medical journal. 2010;3:18–22. [Russian: Захаренко Р. В. Клинические аспекты заболеваний щитовидной железы у пациентов с кардиальной патологией. Дальневосточный медицинский журнал. 2010;3:18-22]
3. Tănase DM, Ionescu SD, Ouatu A, Ambăruş V, Rezuş C, Arsenescu-Georgescu C. Thyroid dysfunction and ischemic heart disease-clinical correlations, progressive implications and impact on the prognosis. Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi. 2014;118(1):63–70. PMID: 24741777
4. Walsh JP, Bremner AP, Bulsara MK, O’Leary P, Leedman PJ, Feddema P et al. Subclinical Thyroid Dysfunction as a Risk Factor for Cardiovascular Disease. Archives of Internal Medicine. 2005;165(21):2467. DOI: 10.1001/archinte.165.21.2467
5. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal. 2016;37(38):2893–962. DOI: 10.1093/eurheartj/ehw210
6. Jones CM, Boelaert K. The Endocrinology of Ageing: A Mini-Review. Gerontology. 2014;61(4):291–300. DOI: 10.1159/000367692
7. Mayskova E. A., Schwartz Yu. G. Latent thyroid pathology in cardiovascular disease and atrial fibrillation fibrillation flow in patients of older age groups. Russian Heart Journal. 2011;10(3):169–77. [Russian: Майскова Е. А., Шварц Ю. Г. Скрытая тиреоидная патология в течении сердечно-сосудистых заболеваний у пациентов старших возрастных групп. Сердце: журнал для практикующих врачей. 2011;10(3):169-77]
8. Takeda N, Maemura K. The role of clock genes and circadian rhythm in the development of cardiovascular diseases. Cellular and Molecular Life Sciences. 2015;72(17):3225–34. DOI: 10.1007/s00018-015-1923-1
9. Mazzoccoli G, Carughi S, Sperandeo M, Pazienza V, Giuliani F, Tarquini R. Neuro-endocrine correlations of hypothalamic-pituitary-thyroid axis in healthy humans. Journal of Biological Regulators and Homeostatic Agents. 2011;25(2):249–57. PMID: 21880214
10. Hildebrandt G, Moser M, Lehofer M. Chronobiologija i chronomedicina biologičeskie ritmy, medicinskoe primenenie: [per. s nem. – M.: Arnebija; 144 p. [Russian: Хильдебрандт Г., Мозер М., Лехофер М. Хронобиология и хрономедицина. Пер. с нем. – М.: Арнебия, 2006. – 144с]. ISBN 978-5-9244-0025-9
11. Russell W, Harrison RF, Smith N, Darzy K, Shalet S, Weetman AP et al. Free Triiodothyronine Has a Distinct Circadian Rhythm That Is Delayed but Parallels Thyrotropin Levels. The Journal of Clinical Endocrinology & Metabolism. 2008;93(6):2300–6. DOI: 10.1210/jc.2007-2674
12. Ehrenkranz J, Bach PR, Snow GL, Schneider A, Lee JL, Ilstrup S et al. Circadian and Circannual Rhythms in Thyroid Hormones: Determining the TSH and Free T4 Reference Intervals Based Upon Time of Day, Age, and Sex. Thyroid. 2015;25(8):954–61. DOI: 10.1089/thy.2014.0589
13. Montalescot G, Sechtem W, Achenbach S, Andreotti F, Arden C, Budaj A et al. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. European Heart Journal. 2013;34(38):2949–3003. DOI: 10.1093/eurheartj/eht296
14. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal. 2013;34(28):2159–219. DOI: 10.1093/eurheartj/eht151
15. Moiseev S. V., Sviridenko N. Yu. Amiodarone induced thyroid dysfunction. Clinical Pharmacology and Therapy. 2012;21(4):33–9. [Russian: Моисеев С. В., Свириденко Н. Ю. Дисфункция щитовидной железы, вызванная амиодароном. Клиническая фармакология и терапия. 2012;21(4):33-9]
16. Bartalena L, Bogazzi F, Chiovato L, Hubalewska-Dydejczyk A, Links TP, Vanderpump M. 2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction. European Thyroid Journal. 2018;7(2):55–66. DOI: 10.1159/000486957
17. Belyaeva Yu. B., Prokhorova S. V., Pchelintseva S. A., Rakhmatullov F. K., Rakhmatullov A. F., Rudakova L. E. The change of hemodynamical and electrophysiological parameters of heart under influence of subclinical dysfunction of a thyroid gland in patients with ischemic disease of the heart with paroxysms of fibrillation of auricles. Bulletin of new medical technologies. 2010;17(1):162–4. [Russian: Беляева Ю. Б., Прохорова С. В., Пчелинцева С. А., Рахматуллов Ф. К., Рахматуллов А. Ф., Рудакова Л. Е. Изменение гемодинамических и электрофизиологических показателей сердца под влиянием субклинической дисфункции щитовидной железы у больных ИБС с пароксизмами фибрилляции предсердий. Вестник новых медицинских технологий. 2010;17(1):162-4]
Review
For citations:
Tsareva Yu.O., Mayskova E.A., Fedotov E.A., Shvarts Yu.G. Circadian rhythms of thyroid hormones in patients with ischemic heart disease, arterial hypertension, and atrial fibrillation. Kardiologiia. 2019;59(3S):23-29. (In Russ.) https://doi.org/10.18087/cardio.2506
Views:
1660
Email this article 
Post a Comment 
